Project Details
PARADIGM
Artificial intelligence or radiologist interpretation for prostate cancer diagnosis
Status:
Upcoming
International, multicentre, within-patient trial investigating whether AI is non-inferior to radiologists in the detection of clinically significant prostate cancer on MRI.

Editorial Summary

PARADIGM at a glance
A prospective, international, within-patient, multicentre, level-1 evidence trial.
Evaluating whether AI is non-inferior to Radiologists in the diagnosis of clinically significant prostate cancer on MRI.
500 patients, 25 centres.